The psychosocial and cognitive impact of longstanding benign multiple sclerosis

Multiple Sclerosis Journal

Volumn 17, Issue 11, 2011, Pages 1375-1383

  Sayao, Ana Luiza ^a   Bueno, Anna Marie ^a   Devonshire, Virginia ^a   Tremlett, Helen ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

benign; depression; fatigue; multiple sclerosis; quality of life

Indexed keywords

BETA INTERFERON; GLATIRAMER; MITOXANTRONE; NATALIZUMAB;

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; BENIGN MULTIPLE SCLEROSIS; COGNITIVE DEFECT; CONTROLLED STUDY; DEPRESSION; DISEASE COURSE; EMPLOYMENT STATUS; FATIGUE; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; MULTIPLE SCLEROSIS; NEUROPSYCHOLOGICAL TEST; PHYSICAL ACTIVITY; PROSPECTIVE STUDY; QUALITY OF LIFE; TREND STUDY;

EID: 80655144771     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458511410343     Document Type: Article

References (41)

1. Kurtzke JF, Beebe GW, Nagler B, Kurland LT, Auth TL. Studies on the natural history of multiple sclerosis-8. Early prognostic features of the later course of the illness. J Chronic Dis. 1977 ; 30: 819-830
2. Thompson AJ, Hutchinson M, Brazil J, Feighery C, Martin EA. A clinical and laboratory study of benign multiple sclerosis. Q J Med. 1986 ; 58: 69-80
3. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG. Multiple sclerosis. N Engl J Med. 2000 ; 343: 938-952
4. Engell T. A clinical patho-anatomical study of clinically silent multiple sclerosis. Acta Neurol Scand. 1989 ; 79: 428-430
5. Rovaris M, Barkhof F, Calabrese M, et al. MRI features of benign multiple sclerosis: toward a new definition of this disease phenotype. Neurology. 2009 ; 72: 1693-1701
6. Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology. 1996 ; 46: 907-911
7. Sayao AL, Devonshire V, Tremlett H. Longitudinal follow-up of benign multiple sclerosis at 20 years. Neurology. 2007 ; 68: 496-500
8. Hawkins SA, McDonnell GV. Benign multiple sclerosis? Clinical course, long term follow up, and assessment of prognostic factors. J Neurol Neurosurg Psychiatry. 1999 ; 67: 148-152
9. Pittock SJ, McClelland RL, Mayr WT, et al. Clinical implications of benign multiple sclerosis: a 20-year population-based follow-up study. Ann Neurol. 2004 ; 56: 303-306
10. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology. 1983 ; 33: 1444-1452
11. Amato MP, Zipoli V, Goretti B, et al. Benign multiple sclerosis: cognitive, psychological and social aspects in a clinical cohort. J Neurol. 2006 ; 253: 1054-1059
12. Rao SM, Leo GJ, Bernardin L, Unverzagt F. Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology. 1991 ; 41: 685-691
13. Pittock SJ, Noseworthy JH, Rodriguez M. MRI findings in benign multiple sclerosis are variable. J Neurol. 2007 ; 254: 539-541
14. Rothwell PM, McDowell Z, Wong CK, Dorman PJ. Doctors and patients dont agree: cross sectional study of patients and doctors perceptions and assessments of disability in multiple sclerosis. BMJ. 1997 ; 314: 1580-1583
15. Bobholz JA, Rao SM. Cognitive dysfunction in multiple sclerosis: a review of recent developments. Curr Opin Neurol. 2003 ; 16: 283-288
16. Amato MP, Zipoli V, Portaccio E. Multiple sclerosis-related cognitive changes: a review of cross-sectional and longitudinal studies. J Neurol Sci. 2006 ; 245: 41-46
17. Amato MP, Ponziani G, Pracucci G, Bracco L, Siracusa G, Amaducci L. Cognitive impairment in early-onset multiple sclerosis. Pattern, predictors, and impact on everyday life in a 4-year follow-up. Arch Neurol. 1995 ; 52: 168-172
18. Achiron A, Barak Y. Cognitive impairment in probable multiple sclerosis. J Neurol Neurosurg Psychiatry. 2003 ; 74: 443-446
19. Patti F, Amato MP, Trojano M, et al. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study. Mult Scler. 2009 ; 15: 779-788
20. Amato MP, Portaccio E, Stromillo ML, et al. Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis. Neurology. 2008 ; 71: 632-638
21. Portaccio E, Stromillo ML, Goretti B, et al. Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis. Neurology. 2009 ; 73: 498-503
22. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol. 1983 ; 13: 227-231
23. Hohol MJ, Orav EJ, Weiner HL. Disease steps in multiple sclerosis: a longitudinal study comparing disease steps and EDSS to evaluate disease progression. Mult Scler. 1999 ; 5: 349-354
24. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961 ; 4: 561-571
25. Beck AT, Rush J, Shaw BF, Emery G Cognitive Therapy of Depression. New York: Guilford Press ; 1979 :
26. Fatigue and Multiple Sclerosis: Evidence-based Management Strategies for Fatigue in Multiple Sclerosis (Clinical Practic Guidelines). Washington, DC: Paralyzed Veterans Association ; 1998 :
27. Flachenecker P, Kumpfel T, Kallmann B, et al. Fatigue in multiple sclerosis: a comparison of different rating scales and correlation to clinical parameters. Mult Scler. 2002 ; 8: 523-526
28. Beck AT, Steer RA, Carbin MG. Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation. Clin Psychol Rev. 1988 ; 8: 77-100
29. Poole H, Bramwell R, Murphy P. The utility of the Beck Depression Inventory Fast Screen (BDI-FS) in a pain clinic population. Eur J Pain. 2009 ; 13: 865-869
30. Vickrey BG, Hays RD, Harooni R, Myers LW, Ellison GW. A health-related quality of life measure for multiple sclerosis. Qual Life Res. 1995 ; 4: 187-206
31. Stewart AL, Hays RD, Ware JE. The MOS short-form general health survey. Reliability and validity in a patient population. Med Care. 1988 ; 26: 724-735
32. Fisk JD, Pontefract A, Ritvo PG, Archibald CJ, Murray TJ. The impact of fatigue on patients with multiple sclerosis. Can J Neurol Sci. 1994 ; 21: 9-14
33. Bakshi R, Shaikh ZA, Miletich RS, et al. Fatigue in multiple sclerosis and its relationship to depression and neurologic disability. Mult Scler. 2000 ; 6: 181-185
34. Sadovnick AD, Remick RA, Allen J, et al. Depression and multiple sclerosis. Neurology. 1996 ; 46: 628-632
35. Gay MC, Vrignaud P, Garitte C, Meunier C. Predictors of depression in multiple sclerosis patients. Acta Neurol Scand. 2010 ; 121: 161-170
36. Pittock SJ, Mayr WT, McClelland RL, et al. Quality of life is favorable for most patients with multiple sclerosis: a population-based cohort study. Arch Neurol. 2004 ; 61: 679-686
37. Visschedijk MA, Uitdehaag BM, Klein M, et al. Value of health-related quality of life to predict disability course in multiple sclerosis. Neurology. 2004 ; 63: 2046-2050
38. Shawaryn MA, Schiaffino KM, LaRocca NG, Johnston MV. Determinants of health-related quality of life in multiple sderosis: the role of illness intrusiveness. Mult Scler. 2002 ; 8: 310-318
39. Glad SB, Nyland H, Aarseth JH, Riise T, Myhr K-M. How long can you keep working with benign multiple sclerosis?. J Neurol Neurosurg Psych. 2011 ; 82: 78-82
40. Statistics Canada. Labour force survey estimates (LFS), by sex and detailed age group, annual (persons unless otherwise noted), 2008. Available at: http://www.statcan.gc.ca (2008,).
41. TrisoliniMHoneycuttAWienerJLesesneS. Global Economic Impact of Multiple Sclerosis. May2010. Available at: http://www.msif.org/document.rm?id=651.